CD4 and neoplasm: Compared to the model group, Sor significantly promoted CD4+ T-cell infiltration in the tumor tissues of tumor-bearing mice (P < 0.05), with the PF group and the combination therapy group exhibiting even stronger effects than the Sor group (P < 0.01).